Document is current
Any future updates will be listed below
-
Authors
Choulli, Maryam https://orcid.org/0000-0001-6029-4969
Kubrak, Catherine
Morey, Francisca
Brenes, Jesús https://orcid.org/0000-0003-0238-3319
Tous, Sara
Quirós, Beatriz
Wang, Xin
Pavón, Miquel Angel
Gomà, Montserrat
Taberna, Miren
Alemany, Laia
Oliva, Marc https://orcid.org/0000-0001-5352-8130
Mena, Marisa
Jha, Naresh
Scrimger, Rufus
Debenham, Brock
Chua, Neil
Walker, John
Mesia, Ricard
Baracos, Vickie https://orcid.org/0000-0002-9609-1001
Arribas, Lorena
- License Information
-
More Information
Article History
Received: 25 July 2024
Revised: 19 November 2024
Accepted: 6 December 2024
First Online: 30 December 2024
Competing interests
: The authors declare no competing interests.
: The present study was developed according to the Declaration of Helsinki and have the ethical approval from the institutional research ethics boards from both countries. For Spain was the Hospital Universitari de Bellvitge Ethics Committee for Clinical Research with the protocol number PR138/19. An informed consent was obtained from all patients included in the Spanish cohort. And for Canada, the Health Research Ethics Board of Alberta (HREBA)—Cancer with the protocol number CC_17-0433. The HREBA approved waiver of an informed consent for the Canadian cohort.
